RaySearch Laboratories AB Statistics
Total Valuation
RaySearch Laboratories AB has a market cap or net worth of GBP 588.90 million. The enterprise value is 592.71 million.
Market Cap | 588.90M |
Enterprise Value | 592.71M |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
Earnings Date | Feb 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.32% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 26.26M |
Valuation Ratios
The trailing PE ratio is 45.73.
PE Ratio | 45.73 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 29.65 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.13, with an EV/FCF ratio of 16.75.
EV / Earnings | 46.03 |
EV / Sales | 6.97 |
EV / EBITDA | 23.13 |
EV / EBIT | 34.13 |
EV / FCF | 16.75 |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.59.
Current Ratio | 1.30 |
Quick Ratio | 1.27 |
Debt / Equity | 0.59 |
Debt / EBITDA | 1.36 |
Debt / FCF | 0.99 |
Interest Coverage | 34.40 |
Financial Efficiency
Return on equity (ROE) is 23.04% and return on invested capital (ROIC) is 11.91%.
Return on Equity (ROE) | 23.04% |
Return on Assets (ROA) | 7.68% |
Return on Invested Capital (ROIC) | 11.91% |
Return on Capital Employed (ROCE) | 18.13% |
Revenue Per Employee | 207,718 |
Profits Per Employee | 31,106 |
Employee Count | 389 |
Asset Turnover | 0.60 |
Inventory Turnover | 5.51 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +154.90% in the last 52 weeks. The beta is 1.34, so RaySearch Laboratories AB's price volatility has been higher than the market average.
Beta (5Y) | 1.34 |
52-Week Price Change | +154.90% |
50-Day Moving Average | 214.51 |
200-Day Moving Average | 163.09 |
Relative Strength Index (RSI) | 67.48 |
Average Volume (20 Days) | 929 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RaySearch Laboratories AB had revenue of GBP 86.00 million and earned 12.88 million in profits. Earnings per share was 0.38.
Revenue | 86.00M |
Gross Profit | 78.31M |
Operating Income | 17.55M |
Pretax Income | 16.86M |
Net Income | 12.88M |
EBITDA | 20.64M |
EBIT | 17.55M |
Earnings Per Share (EPS) | 0.38 |
Balance Sheet
The company has 31.27 million in cash and 35.12 million in debt, giving a net cash position of -3.85 million.
Cash & Cash Equivalents | 31.27M |
Total Debt | 35.12M |
Net Cash | -3.85M |
Net Cash Per Share | n/a |
Equity (Book Value) | 59.63M |
Book Value Per Share | 1.74 |
Working Capital | 15.21M |
Cash Flow
In the last 12 months, operating cash flow was 36.64 million and capital expenditures -1.25 million, giving a free cash flow of 35.39 million.
Operating Cash Flow | 36.64M |
Capital Expenditures | -1.25M |
Free Cash Flow | 35.39M |
FCF Per Share | n/a |
Margins
Gross margin is 91.06%, with operating and profit margins of 20.41% and 14.97%.
Gross Margin | 91.06% |
Operating Margin | 20.41% |
Pretax Margin | 19.61% |
Profit Margin | 14.97% |
EBITDA Margin | 24.00% |
EBIT Margin | 20.41% |
FCF Margin | 41.15% |
Dividends & Yields
RaySearch Laboratories AB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | 39.17% |
Buyback Yield | -0.32% |
Shareholder Yield | -0.32% |
Earnings Yield | 2.19% |
FCF Yield | 6.01% |
Stock Splits
The last stock split was on June 25, 2008. It was a forward split with a ratio of 3.00003.
Last Split Date | Jun 25, 2008 |
Split Type | Forward |
Split Ratio | 3.00003 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |